NDA | Market Exclusive

Home Tags NDA

Two Companies to Watch: Heron Therapeutics Inc (NASDAQ:HRTX) and RedHill Biopharma...

- April 19, 2016 0

Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) Finally Gets an NDA Acceptance for its...

- March 30, 2016 0

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is Preparing to Release PEG-PAL Topline

- March 14, 2016 0

Are Spark Therapeutics Inc (NASDAQ:ONCE) and Five Prime Therapeutics Inc (NASDAQ:FPRX)...

- March 4, 2016 0

Is the Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP) Delay Cause for...

- February 29, 2016 0

Is the Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Pullback an Opportunity?

Roger Hannington - February 25, 2016 2

Synergy Sets up for a Multi-billion Dollar NDA Submission

ME Staff - January 29, 2016 0

The Science Behind Exelixis’ Billion Dollar NDA

Jennifer Aldershot - December 30, 2015 0

Two Potential Approvals to Watch Before the End of the Year

- November 11, 2015 0

Biotech 101: Phase 3 Successful, What’s Next?

Jennifer Aldershot - November 5, 2015 0

1 234 Page 3 of 4

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

May 11, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 27, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 7, 2025

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NDA

Two Companies to Watch: Heron Therapeutics Inc (NASDAQ:HRTX) and RedHill Biopharma...

Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) Finally Gets an NDA Acceptance for its...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is Preparing to Release PEG-PAL Topline

Are Spark Therapeutics Inc (NASDAQ:ONCE) and Five Prime Therapeutics Inc (NASDAQ:FPRX)...

Is the Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP) Delay Cause for...

Is the Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Pullback an Opportunity?

Synergy Sets up for a Multi-billion Dollar NDA Submission

The Science Behind Exelixis’ Billion Dollar NDA

Two Potential Approvals to Watch Before the End of the Year

Biotech 101: Phase 3 Successful, What’s Next?

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY